Pharmacokinetics of Ro 23-6240 (AM 833), a new trifluorinated quinolone.
Weidekamm
E
E
F. Hoffmann-La Roche & Co. Ltd., Department of Clinical Research and Pharmaceutical Research, Basel, Switzerland.
Stöckel
K
K
Dell
D
D
D000284:Administration, Oral; D000890:Anti-Infective Agents / Q000493:pharmacokinetics*; D001682:Biological Availability; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D016576:Fleroxacin; D006207:Half-Life; D006801:Humans; D007262:Infusions, Intravenous; D008657:Metabolic Clearance Rate
D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D016576:Fleroxacin